Search Results - Geert Robaeys
- Showing 1 - 9 results of 9
-
1
Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment by Leen J. M. Heyens, Leen J. M. Heyens, Leen J. M. Heyens, Dana Busschots, Dana Busschots, Ger H. Koek, Ger H. Koek, Geert Robaeys, Geert Robaeys, Geert Robaeys, Sven Francque, Sven Francque
Published in Frontiers in Medicine (2021-04-01)Get full text
Article -
2
-
3
-
4
-
5
Eliminating viral hepatitis C in Belgium: the micro-elimination approach by Dana Busschots, Samira Toghanian, Rob Bielen, Stina Salomonsson, Özgür M. Koc, Greet Hendrickx, Michel Jadoul, Frederik Nevens, Etienne Sokal, Christian Brixko, Kathelijne Peerlinck, Ludwig Apers, Geert Robaeys, Jeffrey V. Lazarus
Published in BMC Infectious Diseases (2020-02-01)Get full text
Article -
6
Forns index and fatty liver index, but not FIB-4, are associated with indices of glycaemia, pre-diabetes and type 2 diabetes: analysis of The Maastricht Study by Annemarie Koster, Ger Koek, Geert Robaeys, Otto Bekers, Simone Eussen, Pieter Dagnelie, Bastiaan de Galan, Casper Schalkwijk, Marleen van Greevenbroek, Coen Stehouwer, Leen Heyens, Hanna Kenjic, Steven Meex, Jeroen Kooman, Hans Savelberg, Martien van Dongen
Published in BMJ Open Gastroenterology (2024-12-01)Get full text
Article -
7
Phylogenetic Analysis of Hepatitis C Virus Infections in a Large Belgian Cohort Using Next-Generation Sequencing of Full-Length Genomes by Kasper T. Christensen, Florian Pierard, David Bonsall, Rory Bowden, Eleanor Barnes, Eric Florence, M. Azim Ansari, Dung Nguyen, Mariateresa de Cesare, Frederik Nevens, Geert Robaeys, Yoeri Schrooten, Dana Busschots, Peter Simmonds, Anne-Mieke Vandamme, Eric Van Wijngaerden, Tim Dierckx, Lize Cuypers, Kristel Van Laethem
Published in Viruses (2023-12-01)Get full text
Article -
8
Risk factors for SARS-CoV-2 infection and severe COVID-19 in unvaccinated solid organ transplant recipients by Casper Vrij, Kris Bogaerts, Pieter Vermeersch, Katrien Lagrou, Geert Molenberghs, Filip Rega, Laurens J. Ceulemans, Dirk Van Raemdonck, Ina Jochmans, Diethard Monbaliu, Jacques Pirenne, Geert Robaeys, Bart De Moor, Tim Vanuytsel, Pieter Gillard, Hélène Schoemans, Johan Van Cleemput, Dirk Kuypers, Robin Vos, Frederik Nevens, Jef Verbeek
Published in Scientific Reports (2024-11-01)Get full text
Article -
9
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study by Evan B. Cunningham, Behzad Hajarizadeh, Olav Dalgard, Janaki Amin, Margaret Hellard, Graham R Foster, Philip Bruggmann, Brian Conway, Markus Backmund, Geert Robaeys, Tracy Swan, Philippa S. Marks, Sophie Quiene, Tanya L Applegate, Martin Weltman, David Shaw, Adrian Dunlop, Julie Bruneau, Håvard Midgard, Stefan Bourgeois, Maria Christine Thurnheer, Gregory J Dore, Jason Grebely, on behalf of the ACTIVATE Study Group
Published in BMC Infectious Diseases (2017-06-01)Get full text
Article
